The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders. In certain embodiments, disclosed herein is an extended-release pharmaceutical formulation comprising, in a solid dosage form for oral delivery of between about 100 mg and about 1 g total weight: between about 2 and about 18% of an active ingredient between about 70% and about 96% of one or more diluents between about 1% and about 10% of a water-soluble binder and between about 0.5 and about 2% of a surfactant.
